Cargando…
Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme
AIMS: Diabetic retinopathy screening aims to detect people at risk of visual loss due to proliferative diabetic retinopathy, but also refers cases of suspected macular oedema (maculopathy). At the introduction of screening, ophthalmology was concerned that referral rates would be unmanageable. We re...
Autores principales: | Looker, H C, Nyangoma, S O, Cromie, D T, Olson, J A, Leese, G P, Black, M W, Doig, J, Lee, N, Lindsay, R S, McKnight, J A, Morris, A D, Pearson, D W M, Philip, S, Wild, S H, Colhoun, H M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033179/ https://www.ncbi.nlm.nih.gov/pubmed/24599419 http://dx.doi.org/10.1136/bjophthalmol-2013-303948 |
Ejemplares similares
-
Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme
por: Looker, H. C., et al.
Publicado: (2013) -
Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland
por: Looker, H. C., et al.
Publicado: (2012) -
Achieved Levels of HbA(1c) and Likelihood of Hospital Admission in People With Type 1 Diabetes in the Scottish Population: A study from the Scottish Diabetes Research Network Epidemiology Group
por: Govan, Lindsay, et al.
Publicado: (2011) -
Risk of Cardiovascular Disease and Total Mortality in Adults with Type 1 Diabetes: Scottish Registry Linkage Study
por: Livingstone, Shona J., et al.
Publicado: (2012) -
Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs
por: Colhoun, H. M., et al.
Publicado: (2012)